Current News from our Company

Virion\Serion receives research funding by the German Federal Ministry of Education and Research (BMBF)

Software solution for comprehensive and automated CSF diagnostics

Our SERION ELISA agile SARS-CoV-2 IgG was tested in an Independent study against 7 assays from competitors.

Fully automatable Anti-SARS-CoV-2 ELISAs based on high quality antigens

We are very happy to announce that the new SERION ELISA classic Dengue Virus superior IgM test will supplement our panel for the detection of tropical infectious diseases.

Fully automatable Anti-SARS-CoV-2 ELISAs based on high antigens

Concerning the global development of the Coronavirus (SARS-CoV-2), Institut Virion\Serion GmbH still assures the continuous supply of our products to our distributors and customers.